RxDoctor Payments Data

Amy Graham

Psychiatric/Mental Health · Farmington, MONPI 1851936736

Payments from drug & device makers

$1,339in general payments, 2019–2025

Across 69 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$717
  • AbbVie$251
  • Teva Pharmaceuticals USA, Inc.$86
  • E.r. Squibb & Sons, L.L.C.$76
  • Axsome Therapeutics, Inc.$65
  • Otsuka America Pharmaceutical, Inc.$61
  • plus $85 from 2 others

What the payments were for

  • Food & beverage$1,339100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,339 in reported general payments places this provider in the 60th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$19,757
Medicare patients
30
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl141$144,698
Abilify MaintenaAripiprazole25$72,635
Invega SustennaPaliperidone Palmitate17$60,437
AuvelityDextromethorphan Hbr/Bupropion57$56,383
CaplytaLumateperone Tosylate31$54,430
RexultiBrexpiprazole32$46,916
Lurasidone Hcl30$10,555
TrintellixVortioxetine Hydrobromide13$6,228
Perphenazine20$2,641
Quetiapine Fumarate128$2,543
Venlafaxine Hcl ErVenlafaxine Hcl225$2,322
Risperidone OdtRisperidone16$1,822
Aripiprazole72$1,711
Clozapine20$1,675
Duloxetine Hcl140$1,486

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$251$144,698141 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$61$119,55057 claims
Axsome Therapeutics, Inc.Auvelity$65$56,38357 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$59$54,43031 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Farmington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →